Vogenx Appoints Gorman as Chief Commercial Officer
Vogenx named board member Richard Gorman as Chief Commercial Officer, tapping his 30-year biopharmaceutical experience to strengthen its commercial strategy and readiness following its IPO.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed